Biotricity is trading 6.84% higher at $0.07; no clear company-specific catalyst was identified for September 24.
- The move extends a volatile decline from $0.11 on September 14, 2026.
- Trading volume was approximately 62.81K shares versus an 87.34K average.
- No company-specific announcement, filing, earnings release, financing, partnership, FDA update, or analyst action was identified for September 24; the newsroomβs latest update was dated September 21. Broader markets were modestly lower, so they do not clearly explain the gain.